Search

Your search keyword '"S. Descamps"' showing total 317 results

Search Constraints

Start Over You searched for: Author "S. Descamps" Remove constraint Author: "S. Descamps"
317 results on '"S. Descamps"'

Search Results

1. Demographic responses of Arctic seabirds to spring sea-ice variations

2. Variation in Antarctic Petrel Foraging Ecology: Not All Individuals Specialize on Krill

Catalog

Books, media, physical & digital resources

3. Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France

4. Antarctic petrels ‘on the ice rocks’: wintering strategy of an Antarctic seabird

5. Validation of Baveno VI and Expanded-Baveno VI Criteria for predicting gastroesophageal varices in patients with alcoholic and non-alcoholic fatty liver disease

7. Worldwide experience of homozygous familial hypercholesterolaemia:retrospective cohort study

8. Implementation of clinical practices and pathways optimizing ACS patients lipid management: Focus on eight European initiatives

9. No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels

10. The upper Hauterivian–Barremian (Lower Cretaceous) Arrifes section (Algarve Basin, Southern Portugal): A palynostratigraphic and palaeoenvironmental approach

12. Belgian data of ODYSSEY APPRISE: stringent LDL-c targets are in reach when using all available tools

13. Comparison of the characteristics at diagnosis and treatment of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries

14. Evolving concepts on the management of dyslipidaemia

15. Comparison of the mutation spectrum and association with pre and post treatment lipid measures of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries

17. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

18. The changing pattern of cirrhosis in Belgium: a study based on two cohorts prospectively collected 15 years apart

19. Tratamiento de los aflojamientos asépticos cotiloideos

20. Trattamento delle mobilizzazioni asettiche cotiloidee

21. Tratamiento quirúrgico de los aflojamientos femorales asépticos. Reconstrucción ósea con aloinjerto y revisión con prótesis cementada

22. Long-term safety, tolerability, and efficacy of evolocumab in patients with heterozygous familial hypercholesterolemia

23. How to implement clinical guidelines to optimise familial hypercholesterolaemia diagnosis and treatment

24. Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action

25. Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM

27. Feasibility and cost of FH cascade screening in Belgium (BEL-CASCADE) including a novel rapid rule-out strategy

28. Systematic review of published Phase 3 data on anti‐PCSK9 monoclonal antibodies in patients with hypercholesterolaemia

29. Frequency and predictors of cholesterol target attainment in patients with stable coronary heart disease in Belgium: results from the Dyslipidemia International Study II (DYSIS II CHD)

30. The role of red yeast rice (RYR) supplementation in plasma cholesterol control: A review and expert opinion

31. Should we expand the indications for the DAIR (debridement, antibiotic therapy, and implant retention) procedure for Staphylococcus aureus prosthetic joint infections? A multicenter retrospective study

32. A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy)

33. Impedance measurement in operating conditions for PLC applications

34. Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

35. The Role of Nutraceuticals in Statin Intolerant Patients

38. Whole exome sequencing of familial hypercholesterolaemia patients negative forLDLR/APOB/PCSK9mutations

39. Understanding IMPROVE-IT and the cardinal role of LDL-C lowering in CVD prevention

40. One-year experience with monoclonal antibodies against PCSK9 in belgian patients with familial hypercholesterolemia

41. Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease

42. Modification of the surfaces of medical devices to prevent microbial adhesion and biofilm formation

43. One-year and longer dual antiplatelet therapy after an acute coronary syndrome: a Belgian position paper Endorsed by the Belgian Interdisciplinary Working Group of Acute Cardiology

44. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society

45. Homozygous familial hypercholesterolemia in childhood: Genotype-phenotype description, established therapies and perspectives

46. Plant sterols and cardiovascular disease: a systematic review and meta-analysis†

47. Management of familial hypercholesterolemia in children and young adults: Consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization

48. Lipoprotein(a) as a cardiovascular risk factor: current status

49. La luxation sternoclaviculaire postérieure

50. Prise en charge des fractures récentes de la clavicule